Regeneron Pharmaceuticals
REGN
REGN
605 hedge funds and large institutions have $32.3B invested in Regeneron Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 226 increasing their positions, 211 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $35.9B → $32.3B (-$3.51B)
22% less call options, than puts
Call options by funds: $973M | Put options by funds: $1.24B
27% less funds holding in top 10
Funds holding in top 10: 22 → 16 (-6)
Holders
605
Holding in Top 10
16
Calls
$973M
Puts
$1.24B
Top Buyers
| 1 | +$218M | |
| 2 | +$145M | |
| 3 | +$84.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.7M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$54.5M |
Top Sellers
| 1 | -$310M | |
| 2 | -$214M | |
| 3 | -$165M | |
| 4 |
Polen Capital Management
Boca Raton,
Florida
|
-$95.1M |
| 5 |
PC
PointState Capital
New York
|
-$78.2M |